Clinical Trials Browser

Phase 1/2 × Irinotecan × Other neoplasm × Clear all

NCT06394713 2024-05-01

A Study to Evaluate the Efficacy and Safety of QLF31907 Combination Therapy in Patients With Advanced Malignant Tumors

Phase 1/2 Not yet recruiting

Advanced Malignant Neoplasm